Y
HN Search
Hacker News Search
new
|
comments
|
top
|
jobs
boltzmannbrain
searching PlanetScale…
1.
▲
2.
▲
3.
▲
4.
▲
5.
▲
6.
▲
13 ms
·
91.
▲
by
boltzmannbrain
7y ago
You don't. And probably not much.
92.
▲
by
boltzmannbrain
7y ago
What is Urbit? https://www.youtube.com/watch?v=M04AKTCDavc Don't know if I'd call it a product per se.
93.
▲
by
boltzmannbrain
7y ago
Latent Sciences: https://latentsci.com Building legit AI solutions (not deep learning (wat?)) to fight the most challenging diseases with broad impact. Yes hiring: https://angel.co/company/latent-sciences&#x
94.
▲
by
boltzmannbrain
7y ago
No. Apples and oranges. I presume the guy running the local AutoZone doesn't aspire to be acquired by Google or Roche for $2 billion. You could make the case for expert chefs or restaurateurs pursuing Michelin stars and fame -- going t
95.
▲
by
boltzmannbrain
7y ago
Because as a founder the startup is your life. It exhausts you mentally, physically, emotionally, financially. If your startup isn't accelerating, it feels like you are wasting your life away at an accelerating pace.
96.
▲
by
boltzmannbrain
7y ago
"... average salaries of Google’s DeepMind staff in Great Britain, which amounted to $345,000 per employee." https://www.top500.org/news/ai-engineers-commanding-six-figu...
97.
▲
by
boltzmannbrain
7y ago
Looks like rather flawed back-of-envelope calculations to get those salary numbers... anyone with more credible sources?
98.
▲
by
boltzmannbrain
7y ago
Also see https://www.dailycodingproblem.com/
99.
▲
by
boltzmannbrain
7y ago
I wonder is there an interesting/useful way to integrate this concept and Tim Urban's time blocks [1]? [1] https://waitbutwhy.com/2016/10/100-blocks-day.html
100.
▲
by
boltzmannbrain
7y ago
AI drug discovery is not an ideal market -- crowded, and long horizons to validation checkpoints. Our value prop to pharma is in clinical trials utilities. Relative to drug discovery, better path from pilots to revenue deals, but still cumb
101.
▲
by
boltzmannbrain
7y ago
> The dogmatic preference for experienced CEOs in biotech is a relatively recent phenomenon (last 15-20 years). I guess it's relative, I'm not even 30 :) FWIW the pushback I get from big pharma is less around age but rather as
102.
▲
by
boltzmannbrain
7y ago
Life Sciences VCs that incubate and spin-out their own companies put serious muscle behind the startups, in two main areas: money and leadership. The article notes the first, going on to suggest large upfront financing is no longer necessar
103.
▲
by
boltzmannbrain
7y ago
hmmm https://www.youtube.com/watch?v=jroQCyWwEgE
104.
▲
by
boltzmannbrain
7y ago
Equations wrong in the original Poincare embeddings paper https://arxiv.org/abs/1705.08039 ? Do you recall which? And thanks for sharing your Lorentz implementation!
105.
▲
by
boltzmannbrain
7y ago
Authors learn embeddings in a Poincaré space rather than Euclidean, better for hierarchical relationships. The reference paper is a good read: Nickel & Kiela '17 "Poincaré Embeddings for Learning Hierarchical Representations&q
106.
▲
by
boltzmannbrain
7y ago
Anyone with open source examples like the couple in the post??
107.
▲
Engineers Hate Your Take-Home Project – Here's How to Fix It (2018)
(angel.co)
2 points
by
boltzmannbrain
7y ago
|
1 comments
108.
▲
by
boltzmannbrain
7y ago
Open source projects on GitHub: https://github.com/23andMe/ https://github.com/color/ https://github.com/recursionpharma/
109.
▲
by
boltzmannbrain
7y ago
GCP has a few case studies that are useful, e.g. Recursion Pharma: https://cloud.google.com/customers/recursion/
110.
▲
Ask HN: Tech Stacks at Healthcare Startups?
2 points
by
boltzmannbrain
7y ago
|
3 comments
111.
▲
by
boltzmannbrain
7y ago
I hope this works seamlessly in my emailing/scheduling workflow, or better yet replaces it entirely. Some quick feedback: 1. Terms of service seem over-bearing (see @whydoineedthis) 2. Show me a demo before making me provide personal i
112.
▲
by
boltzmannbrain
7y ago
I've always had a good handle on my emotions; ftmp from sports psychology training in my college golf days. Meditation reinforces that kind of mindfulness, but to me provides other value... Introspection is very important and useful to
113.
▲
by
boltzmannbrain
7y ago
Latent Sciences | San Francisco & Boston | Software Architect | Onsite Latent Sciences is an AI-first predictive medicines company dedicated to solving neurodegenerative diseases [1]. We're soon emerging from stealth mode, with exc
114.
▲
by
boltzmannbrain
7y ago
These are great. Are they done by hand, or with a drawing tool?
115.
▲
by
boltzmannbrain
7y ago
> different angles Yes, and your example of AuralAnalytics points out the two classes of angles: 1. Different modalities -- brain imaging, voice, eye movements, memory exams, etc* 2. Different diseases -- there are many similarities in u
116.
▲
by
boltzmannbrain
7y ago
Biotech-AI founder here. Already using Brex and love it! On the new life sciences support, 1. How do you know which companies? Do we need to explicitly sign-up/transfer to a life sciences program? 2. Are the life sciences rewards in ad
117.
▲
Science prodigy turned VC on why we need to treat ageing as a disease
(ft.com)
1 points
by
boltzmannbrain
7y ago
|
0 comments
118.
▲
Beyond Black- and White-Box AI
(forbes.com)
3 points
by
boltzmannbrain
7y ago
|
1 comments
119.
▲
by
boltzmannbrain
7y ago
Latent Sciences | San Francisco & Boston | Software Architect | Onsite and Remote Latent Sciences is an AI-first predictive medicines company dedicated to solving neurodegenerative diseases [1]. We're soon emerging from stealth mod
120.
▲
by
boltzmannbrain
7y ago
News websites, if you're going to have a monthly limit of n articles (NYT, HBR, etc.), let me first have the option of continuing to read after loading the page. Too many times following some link (from Hacker News, Twitter, etc.) lead
More ›